Global Coronary Stents Market: Snapshot
The market for coronary stents has been gaining significant traction across the world. Technological advancements, increasing burden of CAD, and the rising base of geriatric population are the main factors that have been fueling the demand for coronary stents substantially. Apart from these, the augmenting demand for minimally invasive procedures and the rising number of percutaneous coronary intervention (PCI) procedures are also supplementing to the growth of this market.
Furthermore, the advancements in bioresorbable vascular scaffold (BVS) and the continual expansion of the leading players in emerging markets are likely to offer significant growth opportunities to the market in the years to come. However, the availability of alternative treatment methods for CAD, strict norms and policies for product approval, and the increasing number of cases of product failure may hamper the growth of this market over the next few years. The market reports a regional presence across the Middle East and Africa, North America, Asia Pacific, Latin America, Europe. Among these, North America has been leading the global market and is expected to retain its supremacy over the forthcoming years.
Global Coronary Stents Market: Overview
Coronary stents are used during the treatment of coronary arteries that supply the heart muscle with blood. A tube-shaped device inserted in coronary arteries, they help open up an artery and are left there permanently.
Fat often gets deposited along the arterial wall, thereby narrowing the area for the blood to flow. This can result in reduced flow of blood to the crucial heart muscle, which in turn can lead to chest pain and heart attack. Clots also form at times, which completely siphon off the flow of blood to the heart causing an attack again. Stents help to thwart such outcomes by keeping the coronary arteries open for the blood to flow smoothly.
Global Coronary Stents Market: Key Trends
Coronary stents are efficient and safe. This unique perceived benefit has been the single most important driver of its market so long. Additionally, clinical research organizations (CROs) with their constant evaluations leveraging clinical trials have egged manufacturers to focus on product development. Such organizations also bring down the time taken for regulatory approvals by partnering with regulatory agencies for pre- and post-market approvals of stents. All these have driven steady growth in the market.
Besides, patients who undergo angioplasty and have stents installed recover faster than patients who have coronary artery bypass surgery (CABG). Coronary stents cause much less discomfort and this has been resulting in their swift adoption too.
Global Coronary Stents Market: Market Potential
Coronary stents play an extremely important role in saving human lives. Recently, the government in India ordered stent manufacturers, especially multinationals Abbot and Medtronic, to not withdraw supply in response to pricing regulations. It cited emergency clause in public interest. Given the crucial function they serve, many governments are coming up with different incentives to make sure everyone can access the lifesaving devices. Some such incentives are reducing the price or providing subsidies.
The three different types of coronary stents available in the market are drug-eluting stents (DES), bare metal stent (BMS), and bioresorbable stent. The drug-eluting stents (DES), among them, grosses maximum revenue on account of the spike in number of people suffering from cardiovascular diseases (CVD). The growing efforts by companies to prove the efficacy of their products through clinical studies has also driven up demand for the product.
In terms of end users, ambulatory surgery centers account for maximum share in the market as they help to minimize medical expenses and lessen the duration of hospital stays. They also come equipped with advanced operating equipment, specialist surgeons, and operating and recovery rooms without complex administrative procedures.
Global Coronary Stents Market: Regional Outlook
From a geographical standpoint, the Americas hold a leading position in the global market for coronary stents due to the advanced medical facilities in the region. Going forward too, the Americas will likely hold on to their leading share.
Global Coronary Stents Market: Competitive Analysis
A large number of regional and international players makes the global market for coronary stents competitive and diversified. These vendors are making constant efforts to outsmart one another by coming up with more cutting-edge devices such as nano-coated stents or through shrewd pricing strategies. They are also resorting to strategic distribution partnerships and mergers and acquisitions to bolster their positions. Some such vendors profiled in the report are Abbott Laboratories, Medtronic, and Boston Scientific.
The study presents reliable qualitative and quantitative insights into:
The regional analysis covers:
The vast market research data included in the study is the result of extensive primary and secondary research activities. Surveys, personal interviews, and inputs from industry experts form the crux of primary research activities and data collected from trade journals, industry databases, and reputable paid sources form the basis of secondary research. The report also includes a detailed qualitative and quantitative analysis of the market, with the help of information collected from market participants operating across key sectors of the market value chain. A separate analysis of macro- and micro-economic aspects, regulations, and trends influencing the overall development of the market is also included in the report.
Highlights of the report:
Note: Immense care has been taken to present data with the highest levels of accuracy in all TMRResearch reports. Nevertheless, recent developments related to market/vendor landscape may take time to reflect in the analysis.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report